Work

Phase1 clinical trial of high doses of Seleno-L-methionine (SLM), in sequential combination with axitinib in previously treated and relapsed clear cell renal cell carcinoma (ccRCC) patients.

Year: 2018

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2018.36.6_suppl.630

Authors: Yousef Zakharia, Rohan Garje, James A. Brown, Kenneth Gerard Nepple, Laila Dahmoush, Katherine Gibson-Corley, Douglas Spitz, Mohammed M. Milhem, Youcef M. Rustum

Institutions: University of Iowa Hospitals and Clinics, University of Iowa Health Care, University of Iowa Holden Comprehensive Cancer Center, Roswell Park Comprehensive Cancer Center

Language: English

Topic: Renal cell carcinoma treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2789679045

Cites:

Cited by: 8

Related to: 10